共找到 38 份报告搜索:诺和诺德

The Obesity Evolution: Refining our Global Anti-Obesity Medication (AOM) Market Model: Oral Options and OUS Poised to Capture Volumes

Goldman Sachs2026-06-0327

Global Healthcare: The Obesity Evolution: Framing global AOM peptide manufacturing capacity and implications for the branded/generic markets

Goldman Sachs2026-06-0545